Literature DB >> 23358810

Lifetime HIV antiretroviral therapy adherence intervention: timing is everything: comment on "Managed problem solving for antiretroviral therapy adherence".

David R Bangsberg1, Jessica E Haberer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23358810      PMCID： PMC4023478          DOI： 10.1001/jamainternmed.2013.2858

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  11 in total

1.  Repeated measures longitudinal analyses of HIV virologic response as a function of percent adherence, dose timing, genotypic sensitivity, and other factors.

Authors:  Honghu Liu; Loren G Miller; Ron D Hays; Carol E Golin; Tongtong Wu; Neil S Wenger; Andrew H Kaplan
Journal:  J Acquir Immune Defic Syndr       Date:  2006-03       Impact factor: 3.731

2.  Treatment resistance after sequential interruption of a non-nucleoside reverse transcriptase inhibitor-based regimen.

Authors:  Sylvie Dargere; Jean-Jacques Parienti; Renaud Verdon
Journal:  AIDS       Date:  2007-04-23       Impact factor: 4.177

3.  The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials.

Authors:  Sharon Mannheimer; Gerald Friedland; John Matts; Carroll Child; Margaret Chesney
Journal:  Clin Infect Dis       Date:  2002-03-11       Impact factor: 9.079

4.  Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda.

Authors:  Edward J Mills; Celestin Bakanda; Josephine Birungi; Keith Chan; Nathan Ford; Curtis L Cooper; Jean B Nachega; Mark Dybul; Robert S Hogg
Journal:  Ann Intern Med       Date:  2011-07-18       Impact factor: 25.391

5.  Prevention of HIV-1 infection with early antiretroviral therapy.

Authors:  Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Sanjay Mehendale; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Lei Wang; Joseph Makhema; Lisa A Mills; Guy de Bruyn; Ian Sanne; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Heather Ribaudo; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David Celentano; Max Essex; Thomas R Fleming
Journal:  N Engl J Med       Date:  2011-07-18       Impact factor: 91.245

6.  Projected life expectancy of people with HIV according to timing of diagnosis.

Authors:  Fumiyo Nakagawa; Rebecca K Lodwick; Colette J Smith; Ruth Smith; Valentina Cambiano; Jens D Lundgren; Valerie Delpech; Andrew N Phillips
Journal:  AIDS       Date:  2012-01-28       Impact factor: 4.177

7.  Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials.

Authors:  Jane M Simoni; Cynthia R Pearson; David W Pantalone; Gary Marks; Nicole Crepaz
Journal:  J Acquir Immune Defic Syndr       Date:  2006-12-01       Impact factor: 3.731

8.  Real-time adherence monitoring for HIV antiretroviral therapy.

Authors:  Jessica E Haberer; Josh Kahane; Isaac Kigozi; Nneka Emenyonu; Peter Hunt; Jeffrey Martin; David R Bangsberg
Journal:  AIDS Behav       Date:  2010-12

9.  Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda.

Authors:  Jessica H Oyugi; Jayne Byakika-Tusiime; Kathleen Ragland; Oliver Laeyendecker; Roy Mugerwa; Cissy Kityo; Peter Mugyenyi; Thomas C Quinn; David R Bangsberg
Journal:  AIDS       Date:  2007-05-11       Impact factor: 4.177

10.  Managed problem solving for antiretroviral therapy adherence: a randomized trial.

Authors:  Robert Gross; Scarlett L Bellamy; Jennifer Chapman; Xiaoyan Han; Jacqueline O'Duor; Steven C Palmer; Peter S Houts; James C Coyne; Brian L Strom
Journal:  JAMA Intern Med       Date:  2013-02-25       Impact factor: 21.873
View more
  4 in total

Review 1.  Actionable Adherence Monitoring: Technological Methods to Monitor and Support Adherence to Antiretroviral Therapy.

Authors:  Kate M Bell; Jessica E Haberer
Journal:  Curr HIV/AIDS Rep       Date:  2018-10       Impact factor: 5.071

2.  Predicting short-term interruptions of antiretroviral therapy from summary adherence data: Development and test of a probability model.

Authors:  Rebecca Arden Harris; Jessica E Haberer; Nicholas Musinguzi; Kyong-Mi Chang; Clyde B Schechter; Chyke A Doubeni; Robert Gross
Journal:  PLoS One       Date:  2018-03-22       Impact factor: 3.240

3.  Alcohol use, antiretroviral therapy adherence, and preferences regarding an alcohol-focused adherence intervention in patients with human immunodeficiency virus.

Authors:  Connie T Kekwaletswe; Neo K Morojele
Journal:  Patient Prefer Adherence       Date:  2014-03-31       Impact factor: 2.711

4.  What causes non-adherence among some individuals on long term antiretroviral therapy? Experiences of individuals with poor viral suppression in Uganda.

Authors:  Dominic Bukenya; Billy Nsubuga Mayanja; Sarah Nakamanya; Richard Muhumuza; Janet Seeley
Journal:  AIDS Res Ther       Date:  2019-01-21       Impact factor: 2.250
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.